Upgrade to SI Premium - Free Trial

Johnson & Johnson (JNJ) PT Raised to $270 at Bernstein SocGen Group

October 15, 2026 8:27 AM
Bernstein SocGen Group analyst Lee Hambright raised the price target on Johnson & Johnson (NYSE: JNJ) to $270.00 (from $261.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change